兴齐眼药：1080582股限售股将于11月7日上市流通

Core Points - The company announced the results of the fourth vesting period for its 2021 restricted stock incentive plan, with a total of 1,080,582 shares vesting, representing 0.44% of the company's total share capital before vesting [1] - A total of 77 individuals are involved in this vesting event, with the vesting date set for November 7, 2025 [1] - The shares from this vesting will be listed and tradable on November 7, 2025, and there is no lock-up period for these restricted shares [1]